Retinopathy of prematurity in extremely low birth weight infants in Malaysia

May May Choo1, Frank Joseph Martin, Lim Chin Theam

  • 1Department of Ophthalmology, University of Malaya, Kuala Lumpur, Malaysia. mmchoo@um.edu.my

Insights

Extremely low birth weight infants born in Malaysia with birth weights under 750g had double the likelihood of requiring treatment for retinopathy of prematurity (ROP). This finding highlights the importance of monitoring ROP in this vulnerable population.

Area of Science:

  • Neonatal Ophthalmology
  • Perinatal Medicine
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • Extremely low birth weight (ELBW) infants are at a higher risk for developing ROP.
  • Understanding risk factors and outcomes in specific populations is crucial for effective management.

Purpose of the Study:

  • To compare the incidence, risk factors, and outcomes of ROP between two birth weight categories of ELBW infants in Malaysia.
  • To identify specific risk factors associated with the need for laser treatment for ROP in this cohort.
  • To assess differences in ROP severity based on birth weight.

Main Methods:

  • Prospective study conducted at the University of Malaya Medical Centre from 2003-2005.
  • Inclusion of ELBW infants, with outcome measures including ROP presence, severity, and laser treatment.
  • Analysis of risk factors for treatment in infants categorized by birth weight (<751 g vs. 751-1,000 g).

Main Results:

  • Of 70 ELBW infants, 58.6% developed ROP and 32.9% required laser treatment.
  • Infants with birth weight <750 g were twice as likely to require treatment (OR = 2).
  • Key risk factors for treatment included gestation <28 weeks, prolonged ventilation, and intraventricular hemorrhage.

Conclusions:

  • The incidence of ROP in Malaysian ELBW infants is comparable to international studies.
  • Lower birth weight (<750 g) significantly increases the likelihood of ROP requiring treatment.
  • Gestational age, ventilation duration, and intraventricular hemorrhage are critical risk factors for ROP treatment in ELBW infants.
Abstract